您的购物车当前为空
别名 E-1224 L-lysine ethanolate, BMS-379224 L-lysine ethanolate
Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate) 是一种口服广谱抗真菌剂,是Ravuconazole 的前药,可研究念珠菌病,灰指甲病和寄生虫病。


为众多的药物研发团队赋能,
让新药发现更简单!
Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate) 是一种口服广谱抗真菌剂,是Ravuconazole 的前药,可研究念珠菌病,灰指甲病和寄生虫病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 179 | 现货 | |
| 5 mg | ¥ 396 | 现货 | |
| 10 mg | ¥ 596 | 现货 | |
| 25 mg | ¥ 1,160 | 现货 | |
| 50 mg | ¥ 1,830 | 现货 | |
| 100 mg | ¥ 2,970 | 现货 | |
| 200 mg | ¥ 4,430 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 646 | 现货 |
Fosravuconazole L-lysine ethanolate 相关产品
| 产品描述 | Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate) is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole. |
| 体外活性 | Fosravuconazole 对包括Candida、Aspergillus和Trichophyton在内的多种真菌物种具有强大的体外抗真菌活性[1]。 |
| 体内活性 | Fosravuconazole (E-1224; 10-50 mg/kg; 口服; 每日; 20天) 的治疗在感染了T. cruzi Y株[2]的小鼠中抑制了寄生虫症并防止了死亡。 |
| 别名 | E-1224 L-lysine ethanolate, BMS-379224 L-lysine ethanolate |
| 分子量 | 739.7 |
| 分子式 | C31H40F2N7O8PS |
| CAS No. | 914361-45-8 |
| Smiles | N#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN |
| 密度 | no data available |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 48 mg/mL (64.89 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.7 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容